To observe the relationship between CDK6 expression and cancer progression, we compared the transcriptional level of CDK6 between MIBC (n = 62) and NMIBC (n = 103) in the GSE13507 cohort (including 165 BLCA cases). Here, CDK6 is linked to bladder transitional cell carcinoma.